苏州正济药业有限公司
Zenji Pharmaceuticals Suzhou Ltd. Xuguan Suzhou Cn
Country: CN CDE+DMF+CEP MEDIUM
🇨🇳 CDE
29
29 products shown
🇺🇸 DMF
8
8 products shown
🇪🇺 CEP
3
3 products shown
Total
40
registrations
🇨🇳 CDE 注册 (29)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Aniracetam 茴拉西坦 | 72432-10-1 | Class A | Y20190004923 |
| Celecoxib 塞来昔布 | 169590-42-5 | Class I | Y20170001197 |
| Citicoline Sodium 胞磷胆碱钠 | 987-78-0 | Class A | Y20190004557 |
| Clindamycin 克林霉素 | - | Class A | Y20190008055 |
| Clopidogrel 氯吡格雷 | 113665-84-2 | Class A | Y20200000777 |
| Clopidogrel 氯吡格雷 | 113665-84-2 | Class A | Y20190008280 |
| Dapagliflozin HS-10353 | 461432-26-8 | Class A | Y20230000874 |
| Dipotassium 磷酸氢二钾 | - | Class A | Y20190008301 |
| Duloxetine 盐酸度洛西汀 | 116539-59-4 | Class A | Y20170000540 |
| Eribulin 甲磺酸艾立布林 | 253128-41-5 | Class I | Y20230000639 |
| Finerenone HS236 | 1050477-31-0 | Class A | Y20240000782 |
| Fluconazole 氟康唑 | 86386-73-4 | Class A | Y20190004563 |
| Lanthanum Carbonate 碳酸镧 | 587-26-8 | Class A | Y20220000535 |
| Meglumine 葡甲胺 | 6284-40-8 | Class A | Y20190004535 |
| Meloxicam 美洛昔康 | 71125-38-7 | Class A | Y20190004536 |
| Mirogabalin 苯磺酸美洛加巴林 | 1138245-13-2 | Class I | Y20250000388 |
| Nicergoline 尼麦角林 | 27848-84-6 | Class A | Y20190006752 |
| Obeticholic Acid 奥贝胆酸 | 459789-99-2 | Class I | Y20200001383 |
| Oseltamivir 磷酸奥司他韦 | 196618-13-0 | Class A | Y20220000844 |
| Pentoxyverine 枸橼酸喷托维林 | 77-23-6 | Class A | Y20190008658 |
| Peramivir 帕拉米韦 | 330600-85-6 | Class A | Y20200001197 |
| Pitavastatin Calcium 匹伐他汀钙 | 147511-69-1 | Class A | Y20230000010 |
| Potassium Dihydrogen 磷酸二氢钾 | 7778-77-0 | Class A | Y20190008934 |
| Potassium Sodium Dehydroandrographolide 炎琥宁 | - | Class A | Y20190006369 |
| Rebamipide 瑞巴派特 | 90098-04-7 | Class A | Y20190009881 |
| Rebamipide 瑞巴派特 | 90098-04-7 | Class A | Y20170000128 |
| Sodium New Houttuyfonate 新鱼腥草素钠 | 112714-99-5 | Class A | Y20190004924 |
| Tazobactam 他唑巴坦 | 89786-04-9 | Class A | Y20190004904 |
| Teprenone 替普瑞酮 | 6809-52-5 | Class I | Y20250000249 |
🇺🇸 DMF 注册 (8)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Dapagliflozin HS-10353 | 461432-26-8 | - | 2024-03-14 |
| Eribulin Fragment A | - | - | 2022-04-29 |
| Eribulin Fragment C14-c26 | - | - | 2024-08-29 |
| Eribulin Intermediate N-5 | - | - | 2023-01-05 |
| Eribulin Intermediate N-6 | - | - | 2021-12-31 |
| Eribulin Mesylate 甲磺酸艾立布林 | 441045-17-6 | - | 2022-09-02 |
| Finerenone HS236 | 1050477-31-0 | - | 2024-10-29 |
| Lanthanum Carbonate 碳酸镧 | 587-26-8 | - | 2023-12-22 |
🇪🇺 CEP 注册 (3)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Celecoxib 塞来昔布 | 169590-42-5 | R1-CEP 2015-029 - Rev 00 | - |
| Clopidogrel Hydrogen Sulfate | 120202-66-6 | CEP 2021-230 - Rev 00 | - |
| Pentoxyverine Hydrogen Citrate | 23142-01-0 | CEP 2024-099 - Rev 01 | - |
Source: ema_cep;FDA_DMF | Updated: 2026-04-09 07:23:02